Clinical Trial

Detection of Early Idiopathic Pulmonary Fibrosis

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 29, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to determine if miR200 family may serve as a biomarker of IPF.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2018-03-06; most recent amendment 2025-12-21.
Status change: Recruiting → Active, Not Recruiting 2024-03-20
Trial Details
NCT Number NCT03457935
Lead Sponsor Temple University
Collaborators: Boehringer Ingelheim
Conditions Idiopathic Pulmonary Fibrosis
Enrollment 450 participants
Start Date 2018-04-10
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-29